Autopsy report · NCT02110316

Bioavailability of Voriconazole

“no eligible patients; study stopped without inclusion”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University Medical Center Groningen

Sponsor type

University, hospital or other

Conditions

Voriconazole; Bioavailability; Critically Ill

Interventions

Dosage form of voriconazole

Participants

0

Sites

1

Countries

Netherlands

Trials that died the same way

• Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism
  “No patient corresponding to inclusion criteria couldn't be enrolled in the study” (88% match in meaning)
• Fluorescence Angiography: Planning and Monitoring of Perforator Flaps
  “The study was stopped due to lack of inclusion” (80% match in meaning)
• Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
  “The study was stopped because there were not enough eligible patients to complete the study.” (80% match in meaning)
• New Prophylactic Maneuver: the "Pushing" Maneuver, Aiming to Reduce the Risk for Shoulder Dystocia
  “the study stopped due to the lack of inclusion.” (79% match in meaning)
• Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen
  “The study was stopped due to lack of inclusions” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.